SCHEMBL25573258

SCHEMBL25573258

CCC1(c2ccc(-c3ccc(Cl)cc3)c3ccccc23)CC2CC[C@@H](C2)C1

nearest known ligand 0.32

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
BCL2 P10415 1/20 0.32
BCL2L1 Q07817 1/20 0.32
BAK1 Q16611 1/20 0.32
PSEN1 P49768 1/20 0.31
PSEN2 P49810 1/20 0.31
APH1B Q8WW43 1/20 0.31
NCSTN Q92542 1/20 0.31
APH1A Q96BI3 1/20 0.31
PSENEN Q9NZ42 1/20 0.31
P2RX7 Q99572 1/20 0.31
KDM1A O60341 1/20 0.31
RCOR1 Q9UKL0 1/20 0.31
SLC6A3 Q01959 4/20 0.30
SLC6A4 P31645 3/20 0.30
MEN1 O00255 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP2C9 P11712 1/20 0.30
CYP2C19 P33261 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26157528 0.83 PSEN1 (0.33) BCL2BCL2L1BAK1PSEN1PSEN2
SCHEMBL25502766 0.77 PTPN11 (0.37) P2RX7MEN1CYP1A2KMT2A
SCHEMBL25517601 0.77 PTPN11 (0.37) P2RX7MEN1CYP1A2KMT2A
SCHEMBL25573615 0.75 MEN1 (0.34) SLC6A3SLC6A4MEN1KMT2A
SCHEMBL19089827 0.70 LMNA (0.46) MEN1KMT2A
SCHEMBL12295925 0.67 CYP1A2 (0.57) SLC6A3SLC6A4CYP1A2KMT2A
SCHEMBL21214803 0.64 CYP1A2 (0.67) MEN1CYP1A2CYP2C9KMT2A
SCHEMBL30363359 0.64 CYP1A2 (0.67) MEN1CYP1A2CYP2C9KMT2A
SCHEMBL23342513 0.63 SLC6A3 (0.38) BCL2BCL2L1BAK1SLC6A3SLC6A4
SCHEMBL23342668 0.62 PDK2 (0.48) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230172055-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230172055-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF OR51E2, NFE2L2, ETV6 BCL2 1356/4885BCL2L1 1165/4885BAK1 3451/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.